Eton Pharmaceuticals Inc
NASDAQ:ETON
Eton Pharmaceuticals Inc
NASDAQ:ETON
Price:
30.45
USD
-4.43%
Market Closed
Market Cap:
$830.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Eton Pharmaceuticals Inc
NASDAQ:ETON
|
US |
|
Valneva SE
PAR:VLA
|
FR |
|
Ford Otomotiv Sanayi AS
IST:FROTO.E
|
TR |
|
MTY Food Group Inc
TSX:MTY
|
CA |
|
Fastenal Co
NASDAQ:FAST
|
US |
|
J
|
JD.Com Inc
NASDAQ:JD
|
CN |
|
P
|
Perk Labs Inc
OTC:PKLBF
|
CA |
|
Ayala Land Inc
XPHS:ALI
|
PH |
|
Tenaris SA
NYSE:TS
|
LU |
|
E
|
EnBW Energie Baden Wuerttemberg AG
F:EBK
|
DE |
|
Advantage Energy Ltd
TSX:AAV
|
CA |
|
D
|
Dynamix Corp
NASDAQ:DYNX
|
US |
|
W
|
Welsbach Technology Metals Acquisition Corp
NASDAQ:WTMA
|
US |
|
Cimpress PLC
NASDAQ:CMPR
|
IE |
|
W
|
Wells Fargo & Co
XMUN:NWT
|
US |
|
C
|
China Molybdenum Co Ltd
OTC:CMCLF
|
CN |
|
Orora Ltd
ASX:ORA
|
AU |
|
Lumine Group Inc
F:Z76
|
CA |
Wall St Price Targets
ETON Price Targets Summary
Eton Pharmaceuticals Inc
Eton Pharmaceuticals Inc
Wall Street analysts forecast ETON stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for ETON is 40.12 USD with a low forecast of 31.31 USD and a high forecast of 54.6 USD.
Lowest Forecast
Price Target
31.31
USD
3% Upside
Average Forecast
Price Target
40.12
USD
32% Upside
Highest Forecast
Price Target
54.6
USD
79% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ETON's stock price target?
Price Target
40.12
USD
40.12
USD
According to Wall Street analysts, the average 1-year price target for ETON is 40.12 USD with a low forecast of 31.31 USD and a high forecast of 54.6 USD.
What is the Revenue forecast for Eton Pharmaceuticals Inc?
Projected CAGR
33%
33%
The compound annual growth rate for Revenue over the next 8 years is 33%.
